UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

Journal of the European Academy of Dermatology and Venereology, 2015-04, Vol.29 (4), p.619-644

2015

Volltextzugriff (PDF)

Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross‐sectional study

British journal of dermatology (1951), 2017-04, Vol.176 (4), p.1042-1047

2017

Volltextzugriff (PDF)

Pathogenesis and pharmacotherapy of Hidradenitis suppurativa

European journal of pharmacology, 2011-12, Vol.672 (1), p.1-8

2011

Volltextzugriff (PDF)

Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions

British journal of dermatology (1951), 2012-01, Vol.166 (1), p.98-106

2012

Volltextzugriff (PDF)

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients

Atherosclerosis, 2007-01, Vol.190 (1), p.1-9

2007

Volltextzugriff (PDF)

Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes

British journal of dermatology (1951), 2011-04, Vol.164 (4), p.838-847

2011

Volltextzugriff (PDF)

Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study

British journal of dermatology (1951), 2021-07, Vol.185 (1), p.177-184

2021

Volltextzugriff (PDF)

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

British journal of dermatology (1951), 2011-06, Vol.164 (6), p.1292-1298

2011

Volltextzugriff (PDF)

Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study

British journal of dermatology (1951), 2014-10, Vol.171 (4), p.819-824

2014

Volltextzugriff (PDF)

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group

Journal of the European Academy of Dermatology and Venereology, 2019-01, Vol.33 (1), p.19-31

2019

Volltextzugriff (PDF)

Current and future treatment of hidradenitis suppurativa

British journal of dermatology (1951), 2020-12, Vol.183 (6), p.e178-e187

2020

Volltextzugriff (PDF)

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin ( IL )‐17A, IL ‐12/23 and CD 20 in hidradenitis suppurativa: an ex vivo study

British journal of dermatology (1951), 2019-08, Vol.181 (2), p.314-323

2019

Volltextzugriff (PDF)

Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision

British journal of dermatology (1951), 2016-03, Vol.174 (3), p.588-593

2016

Volltextzugriff (PDF)

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (IL)‐17A, IL‐12/23 and CD20 in hidradenitis suppurativa: an ex vivo study

British journal of dermatology (1951), 2019-08, Vol.181 (2), p.314-323

2019

Volltextzugriff (PDF)

Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study

British journal of dermatology (1951), 2012-02, Vol.166 (2), p.298-305

2012

Volltextzugriff (PDF)

Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches

British journal of dermatology (1951), 2021-02, Vol.184 (2), p.343-345

2021

Volltextzugriff (PDF)

Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies

British journal of dermatology (1951), 2019-12, Vol.181 (6), p.1339-1341

2019

Volltextzugriff (PDF)

Clinical translation of hidradenitis suppurativa genetic studies requires global collaboration

British journal of dermatology (1951), 2022-01, Vol.186 (1), p.183-185

2022

Volltextzugriff (PDF)

Apocrine Gland–Rich Skin Has a Non-Inflammatory IL-17–Related Immune Milieu, that Turns to Inflammatory IL-17–Mediated Disease in Hidradenitis Suppurativa

Journal of investigative dermatology, 2019-04, Vol.139 (4), p.964-968

2019

Volltextzugriff (PDF)

Quantitative intracellular oxygen availability before and after 5-aminolevulinic acid skin photodynamic therapy

Photodiagnosis and photodynamic therapy, 2021-12, Vol.36, p.102599-102599, Article 102599

2021

Volltextzugriff (PDF)

Primary alterations during the development of hidradenitis suppurativa

Journal of the European Academy of Dermatology and Venereology, 2022-03, Vol.36 (3), p.462-471

2022

Volltextzugriff (PDF)

Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients

British journal of dermatology (1951), 2016-03, Vol.174 (3), p.639-641

2016

Volltextzugriff (PDF)

Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures

Journal of the European Academy of Dermatology and Venereology, 2018-03, Vol.32 (3), p.459-462

2018

Volltextzugriff (PDF)

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials

British journal of dermatology (1951), 2019-11, Vol.181 (5), p.967-975

2019

Volltextzugriff (PDF)

Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice

British journal of dermatology (1951), 2017-12, Vol.177 (6), p.1495-1502

2017

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(78)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(78)

Sprache

Englisch
(78)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(57)
Science & Technology
(57)
Dermatology
(55)
Humans
(52)
Female
(25)
Male
(24)
Middle Aged
(20)
Adult
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Aged
(12)
Hidradenitis Suppurativa - Drug Therapy
(11)
Treatment Outcome
(9)
Psoriasis - Drug Therapy
(8)
Dermatologic Agents - Therapeutic Use
(7)
Original
(7)
Quality Of Life
(7)
Skin Involvement In Other Diseases. Miscellaneous. General Aspects
(7)
Hidradenitis Suppurativa
(6)
Hidradenitis Suppurativa - Epidemiology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa

Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross‐sectional study

Pathogenesis and pharmacotherapy of Hidradenitis suppurativa

Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients

Narrowband ultraviolet B inhibits innate cytosolic double-stranded RNA receptors in psoriatic skin and keratinocytes

Adalimumab and infliximab survival in patients with hidradenitis suppurativa: a daily practice cohort study

Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β

Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study

Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group

Current and future treatment of hidradenitis suppurativa

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin ( IL )‐17A, IL ‐12/23 and CD 20 in hidradenitis suppurativa: an ex vivo study

Recurrence rate of lentigo maligna after micrographically controlled staged surgical excision

The anti‐inflammatory potency of biologics targeting tumour necrosis factor‐α, interleukin (IL)‐17A, IL‐12/23 and CD20 in hidradenitis suppurativa: an ex vivo study

Adalimumab (antitumour necrosis factor-α) treatment of hidradenitis suppurativa ameliorates skin inflammation: an in situ and ex vivo study

Noninvasive assessment of cytokine and antimicrobial peptide levels in hidradenitis suppurativa using transdermal analysis patches

Defining lesional, perilesional and unaffected skin in hidradenitis suppurativa: proposed recommendations for clinical trials and translational research studies

Clinical translation of hidradenitis suppurativa genetic studies requires global collaboration

Apocrine Gland–Rich Skin Has a Non-Inflammatory IL-17–Related Immune Milieu, that Turns to Inflammatory IL-17–Mediated Disease in Hidradenitis Suppurativa

Quantitative intracellular oxygen availability before and after 5-aminolevulinic acid skin photodynamic therapy

Primary alterations during the development of hidradenitis suppurativa

Azathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients

Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures

Adalimumab medium‐term dosing strategy in moderate‐to‐severe hidradenitis suppurativa: integrated results from the phase III randomized placebo‐controlled PIONEER trials

Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice

Suchergebnisse filtern